gip/glp-1 receptor agonist drugs Science Behind GLP 1 GIP and Glucagon Agonists for Obesity Research | News & Announcements Dual GIP/GLP-1 receptor agonists: New
Description
Understand about the investigational Alluvi Retatrutide 40 mg injection a GLP-1 + GIP + Glucagon triple-agonist studied for obesity
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
When you're on a GLP-1, the digestive challenges can be so frustrating and uncomfortable
Berberine has been studied
How do they work
Powerful Probiotic Blend - Berberine makes it easier to maintain weight goals, Chicory (prebiotic fiber) promotes gut health, Probiotics balance belly bacteria, and Turmeric reduces discomfort via antioxidant benefits
